ITM2B Antikörper
Kurzübersicht für ITM2B Antikörper (ABIN2723906)
Target
Alle ITM2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Homo sapiens integral membrane protein 2B (ITM2B)
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Full length human recombinant protein of human ITM2B (NP_068839) produced in HEK293T cell.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- WB 1:2000, IHC 1:150, FLOW 1:100
-
Kommentare
-
The concentration of the product may vary between diferrent lots.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- ITM2B (Integral Membrane Protein 2B (ITM2B))
-
Andere Bezeichnung
- ITM2B
-
Hintergrund
- Amyloid precursor proteins are processed by beta-secretase and gamma-secretase to produce beta-amyloid peptides which form the characteristic plaques of Alzheimer disease. This gene encodes a transmembrane protein which is processed at the C-terminus by furin or furin-like proteases to produce a small secreted peptide which inhibits the deposition of beta-amyloid. Mutations which result in extension of the C-terminal end of the encoded protein, thereby increasing the size of the secreted peptide, are associated with two neurogenerative diseases, familial British dementia and familial Danish dementia.
-
Molekulargewicht
- 30.2 kDa
-
Gen-ID
- 9445
-
NCBI Accession
- NM_021999
-
HGNC
- 9445
Target
-